Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center

Last updated: June 24, 2024
Sponsor: Hospices Civils de Lyon
Overall Status: Active - Recruiting

Phase

N/A

Condition

Brain Injury

Cerebral Ischemia

Stroke

Treatment

Evaluation of program "AVanCer"

Clinical Study ID

NCT05795686
69HCL22_0638
  • Ages > 18
  • All Genders

Study Summary

In France, more than 150,000 strokes occur each year. Stroke is a major risk factor for dependency, representing the leading cause of acquired non-traumatic disability in adults. Head injuries, which are also very frequent, can leave similar neuropsychiatric sequelae.

These events are brutal and their physical, psychological, emotional, social and financial consequences disrupt the lives of patients and their families. Thanks to improved access to thrombolysis and thrombectomy for the management of acute stroke, the prognosis has been profoundly improved. Nevertheless, the increase in post-stroke survival and the evolution of the type of after-effects require the development of support systems dedicated to these post-stroke patients. The same issues are raised for people who have suffered a head injury with similar consequences that require specialised care.

Currently, health care is well structured for the acute phase and there is an improvement in the provision of care in specialised rehabilitation services, but the dedicated medico-social provision for people returning home remains insufficient despite the significant needs. The ARRPAC association (Accompaniment, Rehabilitation, Respite after Stroke and Cerebral Palsy) is setting up a new comprehensive medico-social support programme in Lyon (AVanCer programme, opening in June 2022) to improve the autonomy and adaptation capacities of patients and to relieve the social and psycho-affective burden of carers. This experimental day centre, which complements functional rehabilitation and recurrence prevention care, offers adults with brain injury sequelae and their carers therapeutic education programmes, adapted physical activity, social and cognitive remediation and therapeutic workshops, as well as a place for patients and their carers to exchange information and listen. To achieve its ambition, ARRPAC and the AVanCer programme must be integrated into the existing support offer, create partnerships with care structures and evaluate its added value to ensure its sustainability. In case of efficiency and demonstrated benefits for patients, carers and the health system, such a structure could be deployed in other territories.

This study evaluates the implementation of the AVanCer programme in terms of its effect on the target audience, participants' experience and implementation according to the REAIM evaluative framework (Reach, Effectiveness, Adoption, Implementation, and Maintenance).

Eligibility Criteria

Inclusion

Inclusion Criteria:

For patients :

  • Male or female of legal age

  • Patient who has been selected to start the AVanCer program at the ARRPAC center

  • Patient who has agreed to participate in the PATIENT assessment component and hassigned the consent form

  • Patient able to speak and understand French both orally and in writing

For caregivers :

  • Male or female of legal age

  • Person who has agreed to participate in the CAREGIVING assessment component and hassigned the consent form

  • Person able to speak and understand French both orally and in writing

Population of the qualitative study :

  • Voluntary patients and caregivers who participated in the quantitative part (follow-up by questionnaires)

  • Partner professionals: a sample of 10 representatives of ARRPAC partners whoreferred people for support during the first 12 months, from the followingstructures: public Medicine, Surgery, Obstetric health institution, privateMedicine, Surgery, Obstetric health institution, public Follow-up and RehabilitationCare institution, private Follow-up and Rehabilitation Care institution,medico-social institution, town professionals and user associations.

  • ARRPAC professionals: the 14 ARRPAC professionals involved in the day care centrewill be interviewed in a semi-structured manner

Exclusion

Exclusion Criteria:

  • Pregnant women, parturient or breastfeeding mothers*

  • Persons deprived of their liberty by a judicial or administrative decision

  • Persons under psychiatric care

  • Persons admitted to a health or social establishment for purposes other thanresearch

  • Persons of full age subject to a legal protection measure (guardian, curators)

  • Persons not affiliated to a social security scheme or beneficiaries of a similarscheme

Study Design

Total Participants: 162
Treatment Group(s): 1
Primary Treatment: Evaluation of program "AVanCer"
Phase:
Study Start date:
June 20, 2023
Estimated Completion Date:
April 20, 2026

Connect with a study center

  • Accueil de jour ARRPAC

    Bron, 69500
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.